ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2), accounting for 12 − 17% of all breast cancer cases [1].